Activin receptor-like kinase 7 suppresses lipolysis to accumulate fat in obesity through downregulation of peroxisome proliferator-activated receptor γ and C/EBPα

Diabetes

Volumn 62, Issue 1, 2013, Pages 115-123

  Yogosawa, Satomi ^a   Mizutani, Shin ^a   Ogawa, Yoshihiro ^b   Izumi, Tetsuro ^a  

^a GUNMA UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 7; CCAAT ENHANCER BINDING PROTEIN ALPHA; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; GENOTYPE; GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; LIPOLYSIS; MALE; MOUSE; NONHUMAN; NONSENSE MUTATION; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

3T3-L1 CELLS; ACTIVIN RECEPTORS, TYPE I; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CODON, NONSENSE; DOWN-REGULATION; LIPASE; LIPOLYSIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OBESITY; PPAR GAMMA; SMAD PROTEINS; TRIGLYCERIDES;

EID: 84872037378     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0295     Document Type: Article

References (41)

1. O'Rahilly S. Human genetics illuminates the paths to metabolic disease. Nature 2009;462:307-314
2. Bultman SJ, Michaud EJ, Woychik RP. Molecular characterization of the mouse agouti locus. Cell 1992;71:1195-1204 (Pubitemid 23016553)
3. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432 (Pubitemid 24365442)
4. Wang J, Takeuchi T, Tanaka S, et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic β-cell dysfunction in the Mody mouse. J Clin Invest 1999;103:27-37 (Pubitemid 29031160)
5. Hirayama I, Yi Z, Izumi S, et al. Genetic analysis of obese diabetes in the TSOD mouse. Diabetes 1999;48:1183-1191 (Pubitemid 29226369)
6. Mizutani S, Gomi H, Hirayama I, Izumi T. Chromosome 2 locus Nidd5 has a potent effect on adiposity in the TSOD mouse. Mamm Genome 2006;17:375-384 (Pubitemid 44011963)
7. Suzuki W, Iizuka S, Tabuchi M, et al. A new mouse model of spontaneous diabetes derived from ddY strain. Exp Anim 1999;48:181-189 (Pubitemid 129558684)
8. Ito A, Suganami T, Miyamoto Y, et al. Role of MAPK phosphatase-1 in the induction of monocyte chemoattractant protein-1 during the course of adipocyte hypertrophy. J Biol Chem 2007;282:25445-25452 (Pubitemid 47381264)
9. Listenberger LL, Han X, Lewis SE, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 2003;100:3077-3082 (Pubitemid 36356542)
10. Wang XL, Suzuki R, Lee K, et al. Ablation of ARNT/HIF1β in liver alters gluconeogenesis, lipogenic gene expression, and serum ketones. Cell Metab 2009;9:428-439
11. Wang H, Ishizaki R, Kobayashi E, Fujiwara T, Akagawa K, Izumi T. Loss of granuphilin and loss of syntaxin-1A cause differential effects on insulin granule docking and fusion. J Biol Chem 2011;286:32244-32250
12. Amrani N, Sachs MS, Jacobson A. Early nonsense: mRNA decay solves a translational problem. Nat Rev Mol Cell Biol 2006;7:415-425 (Pubitemid 44050095)
13. Kogame M, Matsuo S, Nakatani M, et al. ALK7 is a novel marker for adipocyte differentiation. J Med Invest 2006;53:238-245 (Pubitemid 44619842)
14. Lafontan M, Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 2009;48:275-297
15. Massagué J. TGF-β signal transduction. Annu Rev Biochem 1998;67:753-791
16. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. Two major Smad pathways in TGF-β superfamily signalling. Genes Cells 2002;7:1191-1204 (Pubitemid 36024597)
17. Schmierer B, Hill CS. TGFβ-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 2007;8:970-982 (Pubitemid 350174642)
18. Massagué J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005;19:2783-2810 (Pubitemid 41739965)
19. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab 2006;4:263-273 (Pubitemid 44430910)
20. Choy L, Derynck R. Transforming growth factor-β inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J Biol Chem 2003;278:9609-9619 (Pubitemid 36800456)
21. Bertolino P, Holmberg R, Reissmann E, Andersson O, Berggren PO, Ibáñez CF. Activin B receptor ALK7 is a negative regulator of pancreatic beta-cell function. Proc Natl Acad Sci USA 2008;105:7246-7251 (Pubitemid 351754463)
22. Andersson O, Korach-Andre M, Reissmann E, Ibáñez CF, Bertolino P. Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity. Proc Natl Acad Sci USA 2008;105:7252-7256 (Pubitemid 351754464)
23. Shen JJ, Huang L, Li L, Jorgez C, Matzuk MM, Brown CW. Deficiency of growth differentiation factor 3 protects against diet-induced obesity by selectively acting on white adipose. Mol Endocrinol 2009;23:113-123
24. Kalderon B, Mayorek N, Ben-Yaacov L, Bar-Tana J. Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo. Am J Physiol Endocrinol Metab 2003;284:E795-E803 (Pubitemid 36323874)
25. Festuccia WT, Laplante M, Berthiaume M, Gélinas Y, Deshaies Y. PPARγ agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control. Diabetologia 2006;49:2427-2436 (Pubitemid 44359105)
26. Kim JY, Tillison K, Lee JH, Rearick DA, Smas CM. The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-α in 3T3-L1 adipocytes and is a target for transactivation by PPARgamma. Am J Physiol Endocrinol Metab 2006;291:E115-E127 (Pubitemid 44035316)
27. Kershaw EE, Schupp M, Guan HP, Gardner NP, Lazar MA, Flier JS. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Am J Physiol Endocrinol Metab 2007;293:E1736-E1745 (Pubitemid 350255127)
28. Wang P, Renes J, Bouwman F, Bunschoten A, Mariman E, Keijer J. Absence of an adipogenic effect of rosiglitazone on mature 3T3-L1 adipocytes: increase of lipid catabolism and reduction of adipokine expression. Diabetologia 2007;50:654-665 (Pubitemid 46215510)
29. Okuno A, Tamemoto H, Tobe K, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998;101:1354-1361 (Pubitemid 28145252)
30. Sugii S, Olson P, Sears DD, et al. PPARγ activation in adipocytes is sufficient for systemic insulin sensitization. Proc Natl Acad Sci USA 2009;106:22504-22509
31. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989;83:1168-1173 (Pubitemid 19113028)
32. Bougnères P, Stunff CL, Pecqueur C, Pinglier E, Adnot P, Ricquier D. In vivo resistance of lipolysis to epinephrine. A new feature of childhood onset obesity. J Clin Invest 1997;99:2568-2573 (Pubitemid 27259802)
33. Langin D, Dicker A, Tavernier G, et al. Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 2005;54:3190-3197 (Pubitemid 43334374)
34. Jocken JW, Langin D, Smit E, et al. Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. J Clin Endocrinol Metab 2007;92:2292-2299 (Pubitemid 46997136)
35. Lu M, Sarruf DA, Talukdar S, et al. Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones. Nat Med 2011;17:618-622
36. Ryan KK, Li B, Grayson BE, Matter EK, Woods SC, Seeley RJ. A role for central nervous system PPAR-γ in the regulation of energy balance. Nat Med 2011;17:623-626
37. Carlsson LM, Jacobson P, Walley A, et al. ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease. Biochem Biophys Res Commun 2009;382:309-314
38. Arner P, Bernard S, Salehpour M, et al. Dynamics of human adipose lipid turnover in health and metabolic disease. Nature 2011;478:110-113
39. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-867 (Pubitemid 46024993)
40. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-783 (Pubitemid 44453463)
41. Lin FT, MacDougald OA, Diehl AM, Lane MD. A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. Proc Natl Acad Sci USA 1993;90:9606-9610 (Pubitemid 23315834)